1. The role of noncoding RNAs in epithelial cancer
- Author
-
Gerry Melino, Eleonora Candi, Massimiliano Agostini, Carlo Ganini, Ganini, Carlo [0000-0002-5839-3965], and Apollo - University of Cambridge Repository
- Subjects
0301 basic medicine ,Cancer Research ,Immunology ,Computational biology ,Review Article ,Biology ,lcsh:RC254-282 ,03 medical and health sciences ,Cellular and Molecular Neuroscience ,0302 clinical medicine ,Circular RNA ,microRNA ,medicine ,631/337/384/331 ,lcsh:QH573-671 ,Regulation of gene expression ,Settore BIO/11 ,lcsh:Cytology ,review-article ,Cancer ,Cell Biology ,medicine.disease ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Long non-coding RNA ,030104 developmental biology ,030220 oncology & carcinogenesis ,Cancer cell ,miRNAs ,Long non-coding RNAs ,631/337/384/2568 ,Human genome ,Function (biology) - Abstract
Funder: RCUK | Medical Research Council (MRC); doi: https://doi.org/10.13039/501100000265, Funder: Fondazione Luigi Maria Monti IDI-IRCCS (RC), Regulatory noncoding RNAs (ncRNAs) are a class of RNAs transcribed by regions of the human genome that do not encode for proteins. The three main members of this class, named microRNA, long noncoding RNA, and circular RNA play a key role in the regulation of gene expression, eventually shaping critical cellular processes. Compelling experimental evidence shows that ncRNAs function either as tumor suppressors or oncogenes by participating in the regulation of one or several cancer hallmarks, including evading cell death, and their expression is frequently deregulated during cancer onset, progression, and dissemination. More recently, preclinical and clinical studies indicate that ncRNAs are potential biomarkers for monitoring cancer progression, relapse, and response to cancer therapy. Here, we will discuss the role of noncoding RNAs in regulating cancer cell death, focusing on those ncRNAs with a potential clinical relevance.
- Published
- 2020
- Full Text
- View/download PDF